Published in Am Surg on July 01, 2003
Locally recurrent colorectal cancer: results of surgical therapy. Langenbecks Arch Surg (2012) 0.76
Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg (2002) 2.71
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol (2003) 2.69
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum (2004) 2.52
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol (2009) 2.50
Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg (2003) 2.16
Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol (2005) 1.92
The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg (2006) 1.90
Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol (2003) 1.73
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg (2002) 1.65
Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum (2010) 1.64
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? Ann Surg Oncol (2004) 1.62
Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity. Virchows Arch (2006) 1.62
Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum (2002) 1.59
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis (2003) 1.59
Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol (2014) 1.59
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol (2004) 1.58
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol (2008) 1.54
Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol (2003) 1.54
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome. Ann Surg Oncol (2004) 1.54
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol (2002) 1.50
T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg (2005) 1.49
Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol (2005) 1.49
Long-term results of local excision for rectal cancer. Ann Surg (2002) 1.44
Feasibility of ex vivo FDG PET of the colon. Radiology (2009) 1.43
Long-term outcome of perianal Paget's disease. Dis Colon Rectum (2003) 1.35
Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum (2005) 1.26
A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol (2006) 1.26
Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessment. Ann Surg Oncol (2007) 1.24
Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum (2007) 1.20
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance. Hum Pathol (2008) 1.14
Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol (2006) 1.07
Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol (2002) 1.06
Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol (2003) 1.05
Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma. Dis Colon Rectum (2002) 1.02
Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum (2004) 1.02
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Canc Netw (2014) 1.01
Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol (2011) 1.01
Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol (2011) 1.01
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum (2004) 1.00
Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis. Radiother Oncol (2013) 1.00
Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys (2005) 0.99
Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol (2009) 0.99
Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Ann Surg Oncol (2011) 0.98
A predictive model for lymph node yield in colon cancer resection specimens. Ann Surg (2011) 0.98
Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance. Hum Pathol (2007) 0.93
Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum (2002) 0.93
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. J Am Coll Surg (2005) 0.93
Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery. J Gastrointest Surg (2002) 0.93
Primary adenocarcinoma of the anus treated with combined modality therapy. Dis Colon Rectum (2003) 0.91
Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment. Ann Surg Oncol (2006) 0.89
Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case. Dis Colon Rectum (2005) 0.89
Abdominoperineal resection for rectal cancer: historic perspective and current issues. Surg Oncol Clin N Am (2005) 0.89
Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst (2005) 0.87
Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument? Ann Surg Oncol (2007) 0.84
Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol (2013) 0.81
Adequacy of distal resection margin following preoperative combined modality therapy for rectal cancer. Ann Surg Oncol (2003) 0.81
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg (2003) 0.81
Accuracy of endorectal ultrasound for measurement of the closest predicted radial mesorectal margin for rectal cancer. Dis Colon Rectum (2012) 0.80
Does endoscopic ultrasound improve detection of locally recurrent anal squamous-cell cancer? Dis Colon Rectum (2015) 0.80
Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders. Clin Colorectal Cancer (2006) 0.79
Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis. Dis Colon Rectum (2009) 0.79
The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. J Am Coll Surg (2005) 0.77
Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome. Ann Surg (2012) 0.77
Ileal diverticulitis: clinical and radiographic presentation. Dig Dis Sci (2004) 0.77
Surgical treatment of rectal cancer: radical resection. Surg Oncol Clin N Am (2006) 0.77
Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome. Fam Cancer (2014) 0.76
Surgical issues in rectal cancer: a 2004 update. Clin Colorectal Cancer (2004) 0.76
Nonoperative strategies for rectal cancer following a complete clinical response to preoperative chemoradiation: a few considerations. Oncology (Williston Park) (2014) 0.75
Multidisciplinary management of resectable rectal cancer. New developments and controversies. Oncology (Williston Park) (2008) 0.75
Improving the vision of colonoscopy: does the fine print really matter? Cancer Prev Res (Phila) (2008) 0.75
Erratum to: Comparing outcomes of robotic versus open mesorectal excision for rectal cancer. BJS Open (2022) 0.75
The genetic counselor: an important surgical ally in the optimal care of the cancer patient. Adv Surg (2012) 0.75